Brief: NorthStrive Biosciences Announces Filing Of 2 U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
21/08/2026 15:23
BRIEF-NorthStrive Biosciences Announces Filing Of 2 U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight Aug 21 (Reuters) - NORTHSTRIVE BIOSCIENCES
NORTHSTRIVE BIOSCIENCES ANNOUNCES THE FILING OF TWO U.S. PATENT APPLICATIONS TARGETING MICROGRAVITY-INDUCED MUSCLE LOSS DURING LONG-DURATION SPACEFLIGHT
Source text: ID:nGNX2cz79X
Further company coverage: ELAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PMGC Holdings
See all newsBrief: PMGC Announces DBA As NorthStrive Holdings Trademark License Agreement, & Website Update
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
Pmgc Holdings Rises As Unit Expands Rights To Ai: discovered obesity, heart disease drug program